A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours

BACKGROUND: There is an urgent need for biomarkers for the early detection of ovarian cancer (OC). The purpose of this study was to assess whether changes in serum levels of lecithin-cholesterol acyltransferase (LCAT), sex hormone-binding globulin (SHBG), glucose-regulated protein, 78 kDa (GRP78), c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Russell, Matthew R, Graham, Ciaren, D'Amato, Alfonsina, Gentry-Maharaj, Aleksandra, Ryan, Andy, Kalsi, Jatinderpal K, Ainley, Carol, Whetton, Anthony D, Menon, Usha, Jacobs, Ian, Graham, Robert L J
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2017
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572165/
https://ncbi.nlm.nih.gov/pubmed/28664912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.199
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados